JP2012508575A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012508575A5 JP2012508575A5 JP2011536276A JP2011536276A JP2012508575A5 JP 2012508575 A5 JP2012508575 A5 JP 2012508575A5 JP 2011536276 A JP2011536276 A JP 2011536276A JP 2011536276 A JP2011536276 A JP 2011536276A JP 2012508575 A5 JP2012508575 A5 JP 2012508575A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- natural killer
- cell population
- pharmaceutical composition
- foxp3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000581 natural killer T-cell Anatomy 0.000 claims 25
- 210000004027 cell Anatomy 0.000 claims 24
- 239000008194 pharmaceutical composition Substances 0.000 claims 23
- 238000000034 method Methods 0.000 claims 10
- 210000000056 organ Anatomy 0.000 claims 10
- 230000028993 immune response Effects 0.000 claims 7
- 210000004185 liver Anatomy 0.000 claims 7
- 210000001744 T-lymphocyte Anatomy 0.000 claims 6
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 6
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 6
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 6
- 235000012012 Paullinia yoco Nutrition 0.000 claims 4
- 238000002054 transplantation Methods 0.000 claims 4
- 108010002350 Interleukin-2 Proteins 0.000 claims 3
- 210000000601 blood cell Anatomy 0.000 claims 3
- 238000006243 chemical reaction Methods 0.000 claims 3
- 210000000265 leukocyte Anatomy 0.000 claims 3
- 230000003472 neutralizing effect Effects 0.000 claims 3
- 239000000021 stimulant Substances 0.000 claims 3
- 102000004127 Cytokines Human genes 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- 108090000172 Interleukin-15 Proteins 0.000 claims 2
- 108010002586 Interleukin-7 Proteins 0.000 claims 2
- 210000005260 human cell Anatomy 0.000 claims 2
- 230000008105 immune reaction Effects 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 230000001965 increasing effect Effects 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 206010025482 malaise Diseases 0.000 claims 2
- 210000004400 mucous membrane Anatomy 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 230000001629 suppression Effects 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 230000003796 beauty Effects 0.000 claims 1
- 230000001079 digestive effect Effects 0.000 claims 1
- 208000024908 graft versus host disease Diseases 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 210000005228 liver tissue Anatomy 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11436208P | 2008-11-13 | 2008-11-13 | |
| US61/114,362 | 2008-11-13 | ||
| PT10476409 | 2009-09-25 | ||
| PT104764 | 2009-09-25 | ||
| PCT/PT2009/000060 WO2010056144A2 (en) | 2008-11-13 | 2009-11-13 | Foxp3+ natural kiler t-cells and the treatment of immune related diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012508575A JP2012508575A (ja) | 2012-04-12 |
| JP2012508575A5 true JP2012508575A5 (enExample) | 2013-01-17 |
Family
ID=42138978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011536276A Pending JP2012508575A (ja) | 2008-11-13 | 2009-11-13 | Foxp3+ナチュラルキラーT細胞および免疫関連疾患の治療方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20120114675A1 (enExample) |
| EP (1) | EP2356222A2 (enExample) |
| JP (1) | JP2012508575A (enExample) |
| CN (1) | CN102216448A (enExample) |
| AU (1) | AU2009314704A1 (enExample) |
| BR (1) | BRPI0915255A2 (enExample) |
| CA (1) | CA2743502A1 (enExample) |
| WO (1) | WO2010056144A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102603892B (zh) * | 2012-02-22 | 2013-10-30 | 尉军 | 一种肿瘤标志物foxp3抗原多肽及应用 |
| ES3040431T3 (en) * | 2014-03-12 | 2025-10-31 | Yeda Res & Dev | Reducing systemic regulatory t cell levels or activity for treatment of disease and injury of the cns |
| EP3838288A1 (en) * | 2014-06-11 | 2021-06-23 | polybiocept GmbH | Expansion of lymphocytes with a cytokine composition for active cellular immunotherapy |
| TWI702290B (zh) * | 2015-04-07 | 2020-08-21 | 富禾生醫股份有限公司 | 經修飾之自然殺手t細胞、醫藥組合物及其用途 |
| CN105039255A (zh) * | 2015-09-09 | 2015-11-11 | 广州赛莱拉干细胞科技股份有限公司 | 一种nkt细胞诱导培养的添加剂及诱导培养的方法 |
| CN107475194B (zh) * | 2017-10-09 | 2018-07-24 | 天津长和生物技术有限公司 | Nkt细胞培养基、培养方法及二者的应用 |
| WO2020215034A1 (en) * | 2019-04-19 | 2020-10-22 | The Regents Of The University Of California | An ampk/caspase-6 axis controls liver damage in nonalcoholic steatohepatitis |
| CN115768879A (zh) | 2020-04-28 | 2023-03-07 | 莱尔免疫制药公司 | 用于培养细胞的方法 |
| WO2025221808A1 (en) * | 2024-04-15 | 2025-10-23 | Trustees Of Tufts College | Efficient epigenetic reprogramming of t effector cells into stable regulatory t cells |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3507486B2 (ja) | 1991-03-15 | 2004-03-15 | アムジエン・インコーポレーテツド | 顆粒球コロニー刺激因子の肺内投与 |
| US5451569A (en) | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
| ATE460475T1 (de) * | 2000-04-11 | 2010-03-15 | Univ Southern California | Methode zur verhinderung der transplantatabstossung unter verwendung von tgf- beta zur induktion von t-suppressorzellen |
| US20060057145A1 (en) * | 2002-10-25 | 2006-03-16 | Government Of The United States Of America As Represented By The Secretary, Dept. Of Health | Methods to prevent tumor recurrence by blockade of tgf-beta |
-
2009
- 2009-11-13 EP EP09764330A patent/EP2356222A2/en not_active Withdrawn
- 2009-11-13 AU AU2009314704A patent/AU2009314704A1/en not_active Abandoned
- 2009-11-13 BR BRPI0915255A patent/BRPI0915255A2/pt not_active IP Right Cessation
- 2009-11-13 CN CN2009801452249A patent/CN102216448A/zh active Pending
- 2009-11-13 US US13/129,146 patent/US20120114675A1/en not_active Abandoned
- 2009-11-13 JP JP2011536276A patent/JP2012508575A/ja active Pending
- 2009-11-13 CA CA2743502A patent/CA2743502A1/en not_active Abandoned
- 2009-11-13 WO PCT/PT2009/000060 patent/WO2010056144A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012508575A5 (enExample) | ||
| Pieren et al. | The adaptive immune system in early life: The shift makes it count | |
| Fina et al. | Regulation of gut inflammation and th17 cell response by interleukin-21 | |
| Heiseke et al. | CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell–mediated protection from colitis | |
| Schnupf et al. | Segmented filamentous bacteria, Th17 inducers and helpers in a hostile world | |
| Sarra et al. | Il-23/Il-17 Axis in IBD | |
| Lang et al. | How important is vitamin D in preventing infections? | |
| Nikolich-Žugich | Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections | |
| Wu et al. | Microbiota-specific Th17 cells: Yin and Yang in regulation of inflammatory bowel disease | |
| CN102271702B (zh) | 抗第三方中枢记忆性t细胞、产生其的方法及其在移植和疾病治疗中的用途 | |
| Moschen et al. | Interferon-alpha controls IL-17 expression in vitro and in vivo | |
| Secombes et al. | Overview of the fish adaptive immune system | |
| JP2012515213A5 (enExample) | ||
| JP2015536659A (ja) | 阻害性オリゴヌクレオチド及びその使用 | |
| Jiang et al. | Immunization with adenovirus LIGHT-engineered dendritic cells induces potent T cell responses and therapeutic immunity in HBV transgenic mice | |
| Ahlberg et al. | Innate immune responses induced by the saponin adjuvant Matrix-M in specific pathogen free pigs | |
| Madan et al. | Cenicriviroc, a CCR2/CCR5 antagonist, promotes the generation of type 1 regulatory T cells | |
| Schrum et al. | Bacterial infection induces expression of functional MHC class II molecules in murine and human osteoblasts | |
| JP2008534620A (ja) | 制御性t細胞を用いた移植組織の拒絶反応の防止 | |
| Lozano‐Ojalvo et al. | Oral immunotherapy with egg peptides induces innate and adaptive tolerogenic responses | |
| Lin et al. | The co-administrating of recombinant porcine IL-2 could enhance protective immune responses to PRV inactivated vaccine in pigs | |
| ES2731849T3 (es) | Composiciones para la inducción específica de antígeno de inmunotolerancia mediante inmunización oral | |
| Jungraithmayr | The putative role of mast cells in lung transplantation | |
| Zhao et al. | Mesenteric CD103+ DCs initiate switched coxsackievirus B3 VP1-specific IgA response to intranasal chitosan-DNA vaccine through secreting BAFF/IL-6 and promoting Th17/Tfh differentiation | |
| Sakthivel et al. | CCL5 regulation of mucosal chlamydial immunity and infection |